FDA Issues Final Guidance on Pivotal Trials for Opioid Use Disorder Devices

The FDA has finalized its guidance on crafting phase 3 clinical trials for devices designed to treat opioid use disorder (OUD), providing sponsors with direction on defining patient populations, recording medication use, monitoring drug use and other elements.
Source: Drug Industry Daily